news
CRISPR approach could limit toxicity of CAR-T therapy in AML
New study uses CRISPR/Cas9 to make CD33 CAR T cells…
New study uses CRISPR/Cas9 to make CD33 CAR T cells cancer-specific...
List view / Grid view
New study uses CRISPR/Cas9 to make CD33 CAR T cells…
New study uses CRISPR/Cas9 to make CD33 CAR T cells cancer-specific...